GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » Cyclically Adjusted Book per Share

CTI BioPharma (FRA:CEPS) Cyclically Adjusted Book per Share : €0.00 (As of Mar. 2023)


View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CTI BioPharma's adjusted book value per share for the three months ended in Mar. 2023 was €-0.180. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-19), CTI BioPharma's current stock price is €8.106. CTI BioPharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was €0.00. CTI BioPharma's Cyclically Adjusted PB Ratio of today is .


CTI BioPharma Cyclically Adjusted Book per Share Historical Data

The historical data trend for CTI BioPharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma Cyclically Adjusted Book per Share Chart

CTI BioPharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CTI BioPharma Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CTI BioPharma's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, CTI BioPharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTI BioPharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTI BioPharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CTI BioPharma's Cyclically Adjusted PB Ratio falls into.



CTI BioPharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CTI BioPharma's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book= Book Value per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.18/127.3478*127.3478
=-0.180

Current CPI (Mar. 2023) = 127.3478.

CTI BioPharma Quarterly Data

Book Value per Share CPI Adj_Book
201306 0.112 98.518 0.145
201309 0.148 98.790 0.191
201312 2.266 98.326 2.935
201403 1.247 99.695 1.593
201406 0.460 100.560 0.583
201409 0.981 100.428 1.244
201412 1.916 99.070 2.463
201503 0.906 99.621 1.158
201506 -0.583 100.684 -0.737
201509 -1.081 100.392 -1.371
201512 1.703 99.792 2.173
201603 1.912 100.470 2.423
201606 1.320 101.688 1.653
201609 0.564 101.861 0.705
201612 0.447 101.863 0.559
201703 -0.156 102.862 -0.193
201706 0.901 103.349 1.110
201709 0.645 104.136 0.789
201712 0.429 104.011 0.525
201803 1.158 105.290 1.401
201806 1.024 106.317 1.227
201809 0.844 106.507 1.009
201812 0.890 105.998 1.069
201903 0.768 107.251 0.912
201906 0.622 108.070 0.733
201909 0.500 108.329 0.588
201912 0.368 108.420 0.432
202003 0.346 108.902 0.405
202006 0.685 108.767 0.802
202009 0.539 109.815 0.625
202012 0.434 109.897 0.503
202103 0.292 111.754 0.333
202106 0.549 114.631 0.610
202109 0.342 115.734 0.376
202112 0.033 117.630 0.036
202203 -0.252 121.301 -0.265
202206 -0.044 125.017 -0.045
202209 -0.134 125.227 -0.136
202212 -0.127 125.222 -0.129
202303 -0.180 127.348 -0.180

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


CTI BioPharma  (FRA:CEPS) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CTI BioPharma Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CTI BioPharma (FRA:CEPS) Business Description

Industry
Traded in Other Exchanges
N/A
Address
3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (FRA:CEPS) Headlines

No Headlines